Portions of Exhibit 10.2 have been redacted and are the subject of a confidential treatment request filed with the Secretary of the Securities and Exchange Commission. 2 ANADERM RESEARCH CORP. Amended and Restated Stockholders' Agreement dated April...Stockholders' Agreement • August 16th, 1999 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
betweenAsset Purchase Agreement • August 16th, 1999 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
AMENDMENT NO. 1 to the Collaborative Agreement dated as of April 19, 1995 between Novartis Pharma AG and OSI Pharmaceuticals, Inc.Collaborative Agreement • August 16th, 1999 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
andOsi Pharmaceuticals Inc • August 16th, 1999 • In vitro & in vivo diagnostic substances • New York
Portions of this Exhibit 10.1 have been redacted and are the subject of a confidential treatment request filed with the Secretary of the Securities and Exchange Commission. 2 COLLABORATIVE RESEARCH AGREEMENT This amended and restated COLLABORATIVE...Collaborative Research Agreement • August 16th, 1999 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Portions of Exhibit 10.3 have been redacted and are the subject of a confidential treatment request filed with the Secretary of the Securities and Exchange Commission. 2 DEVELOPMENT AGREEMENT This DEVELOPMENT AGREEMENT is entered into as of April 1,...Development Agreement • August 16th, 1999 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
